[The NFAT transcription factor family as immunosuppression target].
Ortega-Pérez
I
I
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Facultad de Ciencias, Madrid.
Redondo
J M
JM
D016572:Cyclosporine / Q000627:therapeutic use; D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D013601:T-Lymphocytes; D016559:Tacrolimus / Q000627:therapeutic use; D014157:Transcription Factors / Q000235:genetics*
D004268:DNA-Binding Proteins; D007166:Immunosuppressive Agents; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors; D016572:Cyclosporine; D016559:Tacrolimus